A retrospective study illustrated that T2DM Covid-19 patients with blood glucose 3.910.0 mml/l were associated with low mortality (Zhu et al
et al, Growth hormone secretagogues: history, mechanism of action, and clinical development, JSCM Rapid Communications Vol
Early clinical trials have shown promising weight-loss results, but it's important to understand that retatrutide remains investigational and has not yet received FDA approval
What testing was performed for identity, potency, sterility, and endotoxins
Funding The author(s) declared that financial support was not received for this work and/or its publication
Intervention groups knew they were receiving the supplements, which puts the study at a huge risk for bias